Focus Therapy

Aprazer Healthcare: Therapeutics for Critical Healthcare Needs

At Aprazer Healthcare, we develop therapeutics addressing the most vulnerable conditions that require more than the standard solution.

We are a global pharmaceutical company dedicated to developing quality-driven, affordable therapeutics — bridging healthcare gaps through timely intervention and precision medicines for critical health conditions.

We stand out by combining scientific precision with empathy to develop therapeutics for high-priority and most vulnerable medical needs, including:

• • Life-altering or rare conditions
• • High-priority medical needs
• • Risk and threat scenarios
• • Specialty care therapeutics

Therapeutic Areas & Portfolio

Respiratory & Pulmonary Care

• • Pirfekast – Pirfenidone
• • Bosenzer – Bosentan

Antiviral & Infectious Disease Management

• • Favikast – Favipiravir (rapid-response antiviral)
• • Tamikast – Oseltamivir

Cardiovascular Emergency & Hypertension

• • Labzer – Labetalol Hydrochloride

Anti-Parasitic & GI

• • Iverkast – Ivermectin
• • Sobiaxis – Sodium Bicarbonate
• • Zerquan – Praziquantel

Aprazer Healthcare Impacting Globally

• • Products available in more than 20+ countries
• • Treatment for over 10+ life-threatening conditions
• • Therapeutic efficacy and regulatory excellence
• • Trusted by healthcare professionals worldwide

Aprazer Healthcare — A Global Partner in Progress

We actively collaborate with distributors, healthcare institutions, and innovators around the world to deliver affordable and best-quality critical therapeutics to those who need them most.

"We believe collaboration drives change—together, we can transform the global healthcare landscape."